Neuronal Acetylcholine Receptor Subunit Beta 2 (chrnb2) Drugs In Development By Therapy Areas
February 3, 2023 ⚊ 1 Min read ⚊ Views 89 ⚊ TECHNOLOGY
Neuronal acetylcholine receptor subunit beta-2 (CHRNB2) is a protein encoded by the CHRNB2 gene. Acetylcholine binds to this receptor and results in extensive change in conformation. This affects all subunits and leads to the opening of an ion-conducting channel across the plasma membrane permeable to sodium ions.
The CHRNB2 pipeline market research report provides comprehensive information on CHRNB2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in Neuronal Acetylcholine Receptor Subunit Beta 2 (CHRNB2) targeted therapeutics development with respective active and dormant or discontinued projects.
